Literature DB >> 7040198

Plasma glucose and insulin response to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release.

P R Flatt, C J Bailey.   

Abstract

Fed adult obese hyperglycaemic (ob/ob) mice fail to produce a positive plasma insulin response to an intraperitoneal (ip) glucose challenge. The present study demonstrates that both fed and fasted ob/ob mice produce a marked positive plasma insulin response to an ip challenge by glucagon or arginine throughout the phases of development and regression of the ob/ob syndrome. These observations provide evidence that failure of the B-cells to respond to glucose in fed adult ob/ob mice cannot be attributed to inadequate amounts of releasable insulin. In addition, the results show that the B-cells of fed adult ob/ob mice do not incur a generalized defect of stimulus-recognition-secretion-coupling.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040198     DOI: 10.1055/s-2007-1018945

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Macroalgal protein hydrolysates from Palmaria palmata influence the 'incretin effect' in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion.

Authors:  C M McLaughlin; P A Harnedy-Rothwell; R A Lafferty; S Sharkey; V Parthsarathy; P J Allsopp; E M McSorley; R J FitzGerald; F P M O'Harte
Journal:  Eur J Nutr       Date:  2021-06-03       Impact factor: 5.614

2.  A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.

Authors:  Rachele A Perry; Sarah L Craig; Victor A Gault; Peter R Flatt; Nigel Irwin
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

3.  Physicochemical, Nutritional and In Vitro Antidiabetic Characterisation of Blue Whiting (Micromesistiuspoutassou) Protein Hydrolysates.

Authors:  Pádraigín A Harnedy-Rothwell; Neda Khatib; Shaun Sharkey; Ryan A Lafferty; Snehal Gite; Jason Whooley; Finbarr Pm O'Harte; Richard J FitzGerald
Journal:  Mar Drugs       Date:  2021-07-02       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.